Molecular Diagnostics for Transplant Market is predicted to reach USD 1.40 billion at a CAGR of ~8.91% during the forecast period 2023 to 2030.

Market Research Future (MRFR) has published a cooked research report on the “Global Molecular Diagnostics for Transplant Market” that contains the information from 2018 to 2030. The molecular diagnostics for transplant market is projected to register a CAGR of 8.91% during the forecast period of 2022 to 2030.

Molecular Diagnostics for Transplant Market Highlights

The global molecular diagnostics for transplant market is accounted to register a CAGR of 8.91% during the forecast period and is estimated to reach USD 1.40 billion by 2030.

Molecular diagnostics provides tremendous advantages such as sensitivity, rapid & high-throughput analysis, and is effective for immunocompromised patients. It has the ability to detect infections earlier than previously possible.

The global molecular diagnostics for transplant market is growing due to the increasing prevalence of infectious diseases, advancements in molecular diagnostic techniques, and increasing number of transplant procedures. However, stringent rules & regulations for product approval and dearth of skilled labor are hampering the growth of the market. In contrast, there is a growing public awareness about organ donation and transplantation which is expected to boost the market growth.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Molecular-Diagnostics For transplant  Market

Segment Analysis

The global molecular diagnostics for transplant market has been segmented based on product, technology, and end user.

On the basis of product, the market is segmented into reagents & kits, instruments, and services & software. The reagents & kits segment held the largest market in 2021.

Based on technology, the market is segmented into Polymerase Chain Reaction (PCR), sequencing, microarray, and others. The reagents & kits segment held the largest market in 2021.

The global molecular diagnostics for transplant market, on the basis of end user, has been segmented into hospitals and transplant centers, research laboratories & academic institutes, and others. The polymerase chain reaction (PCR) segment held the largest market in 2021.

Regional Analysis

The global molecular diagnostics for transplant market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe molecular diagnostics for transplant market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The molecular diagnostics for transplant market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The rest of the world molecular diagnostics for transplant market comprises of Middle East, Africa, and Latin America.

The North American molecular diagnostic for transplant market has been expanding rapidly owing to the rising demand technology evolution and increasing incidences of chronic diseases that lead to an increase in organ transplants. According to research, the number of kidneys, liver, heart, lung, pancreas, and intestine transplant is increasing in the US, while the number of kidney transplants is increasing in Canada.

Moreover, the high demand for advanced molecular diagnostics for transplants in Europe region is owing to the rising prevalence of chronic diseases, including kidney, cardiovascular diseases (CVD), and respiratory diseases. Advancements in molecular diagnostics have improved the identification and understanding of specific gene defects for the appropriate organ transplant in kidney, heart, and lung failure.

Furthermore, the Asia-Pacific region's growing geriatric population is increasing demands of organ transplantation, which may vary as per organ failure. In 2020, according to the World Economic Forum, China, India, and Japan had the oldest populations in the globe. Also, it has been estimated that by 2050, one in four aged people will be living in the region. The main causes of organ failure in the geriatric population are pulmonary infection, metastatic carcinoma, and cardiac attack, which fuels the region's growth.

In addition, the rest of the world comprises the Middle East, Latin America, and Africa. There is a demand for renal and extra-renal transplantation in Latin America owing to chronic kidney diseases. Latin America accounts for the highest global incidence of kidney failure. Likewise, in Africa, people are suffering from life-threatening diseases. Because of this, the demand for life-saving organs demand is high in the region.

Key Findings of the Study

• The global molecular diagnostics for transplant market is expected to reach USD 1.40 billion by 2030 at a CAGR of 8.91% during the forecast period.


• The Asia-Pacific region accounted for the fastest growing of the global market, owing to the growing geriatric population and change in lifestyle that leads to life-threatening diseases like diabetes, liver failure, and obesity among the region’s population.


• Based on technology, the polymerase chain reaction (PCR) segment held the largest market in 2021, with a market share of 34.59%.


• Thermo Fisher Scientific, Inc. (US), BioMérieux SA (France), Cepheid (US), Altona Diagnostics GmbH (Germany), ELITechGroup (France), F. Hoffmann-La Roche Ltd (Switzerland), Hologic Inc. (US), QIAGEN N.V. (Germany), Becton, Dickinson, and Company (US), Abbott Laboratories, Inc. (US), and others.


• MRFR recognizes the following companies as the key players in the global molecular diagnostics for transplant market— Thermo Fisher Scientific, Inc. (US), BioMérieux SA (France), Cepheid (US), Altona Diagnostics GmbH (Germany), ELITechGroup (France), F. Hoffmann-La Roche Ltd (Switzerland), Hologic Inc. (US), QIAGEN N.V. (Germany), Becton, Dickinson, and Company (US), Abbott Laboratories, Inc. (US), and others.